Penicillin G Potassium Injection, Powder, For Solution
NDC Package 0781-6136-94

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

Penicillin G Potassium injection is a medication used to treat a wide variety of bacterial infections. This formulation utilizes a injection, powder, for solution delivery system. Marketed by Sandoz Inc, this product is identified by NDC 0781-6136 and is authorized under FDA application ANDA065079.

Identification & Billing

NDC Package Code
0781-6136-94
Package Description
1 VIAL in 1 CARTON / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL
Product Code
11-Digit Billing Format
00781613694
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
1 EA
RxNorm Crosswalk
  • RxCUI: 863538 - penicillin G potassium 1,000,000 UNT/ML Injectable Solution
  • RxCUI: 863538 - penicillin G potassium 1000000 UNT/ML Injectable Solution
  • RxCUI: 863538 - Penicillin G K+ 1000000 UNT/ML Injectable Solution
  • RxCUI: 863538 - Penicillin G Pot 1000000 UNT/ML Injectable Solution
  • RxCUI: 863538 - penicillin G potassium 20,000,000 UNT per 11.5 ML Injectable Solution

Clinical Specifications

Proprietary Name
Penicillin G Potassium
Non-Proprietary Name
Penicillin G Potassium
Substance Name
Penicillin G Potassium
Dosage Form
Injection, Powder, For Solution - A sterile preparation intended for reconstitution to form a solution for parenteral use.
Administration Route
  • Intramuscular - Administration within a muscle.
  • Intravenous - Administration within or into a vein or veins.
Usage Information
This medication is used to treat a wide variety of bacterial infections. It is also used to prevent infection of the heart (bacterial endocarditis) in patients with certain heart diseases who are having surgery. This medication is known as a natural penicillin antibiotic. It works by stopping the growth of bacteria.

Regulatory & Marketing

Labeler Name
Sandoz Inc
Product Type
Human Prescription Drug
FDA Application #
ANDA065079
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
08-30-2001
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Billing & HCPCS Mapping

To facilitate insurance claims and reimbursement, this drug package is mapped to specific HCPCS administrative codes. This crosswalk aligns clinical data with the billing standards used in ASP (Average Sales Price), AWP, and OPPS payment systems. Use the cards below to identify the correct billable units for provider claims.

Source: PDAC
INJECTION, PENICILLIN G POTASSIUM, UP TO 600,000 UNITS
HCPCS Dosage 600000 U
Units / Pkg

Note for Medical Coders: These mappings are synthesized from various CMS datasets including OPPS, PrEP, and DAC (Data Analysis and Coding) contractors. Always confirm unit conversions against the current quarter's pricing files before final submission.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0781-6136-94 identifies a specific commercial package of 1 vial in 1 carton / 1 injection, powder, for solution in 1 vial of Penicillin G Potassium, a human prescription drug labeled by Sandoz Inc. This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package. This injection, powder, for solution is formulated for intramuscular; intravenous use and contains penicillin g potassium as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Sandoz Inc on August 30, 2001. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

This medication is used to treat a wide variety of bacterial infections. It is also used to prevent infection of the heart (bacterial endocarditis) in patients with certain heart diseases who are having surgery. This medication is known as a natural penicillin antibiotic. It works by stopping the growth of bacteria.

How is this Sandoz Inc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00781613694. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0781-6136-94
11-Digit CMS (5-4-2)
00781-6136-94

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.